Multicellular living organisms and unmodified parts thereof and – Method of using a transgenic nonhuman animal to manufacture... – The protein is isolated or extracted from milk
Reexamination Certificate
2005-01-24
2008-10-14
Crouch, Deborah (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Method of using a transgenic nonhuman animal to manufacture...
The protein is isolated or extracted from milk
C800S014000, C800S015000, C800S016000, C800S017000, C800S018000, C514S012200
Reexamination Certificate
active
07435869
ABSTRACT:
A transgenic, non-human mammalian animal is capable of expressing a heterologous gene for human or other recombinant physiologically functional fibrinogen holoprotein or individual subunit chain polypeptides thereof or a modified or fusion fibrinogen in mammary glands of the animals and secreting the expressed product into a body fluid. Methodology employing such a mammal yields recombinant physiologically functional fibrinogens, subunit chain polypeptides thereof, and modified or fusion fibrinogens.
REFERENCES:
patent: 4873316 (1989-10-01), Meade et al.
patent: 5304489 (1994-04-01), Rosen et al.
patent: 0 264 166 (1988-04-01), None
patent: WO 88/00239 (1988-01-01), None
patent: WO 88/01648 (1988-03-01), None
patent: WO 92/11757 (1992-07-01), None
Houdebine. Transgenic Animal Bioreactors. Transgenic Res. 2000, vol. 9, pp. 305-320.
Kerr et al. The Bladder as Bioreactor: Urothelium Production and Secretion of Growth Hormone into Urine. Nature Biotechnology. Jan. 1998, vol. 16, pp. 75-79.
Binnie et al., “Characterization of Purified Recombinant Fibrinogen: Partial Phosphorylation of Fibrinopeptide A,”Biochemistry32:107-113 (1993).
Boylard et al., “Expression inEscherichia coliof the Human Fibrinogen Bβ Chain and Its Cleavage by Thrombin,”Blood73(5):1202-1206 (1989).
Cecil Textbook of Medicine,W.B. Saunders Company, Philadelphia, J.B. Wyngaarden et al. 18th Ed., vol. 1, pp. 1061, 1063-1064, 1071-1074 (1988).
Chung et al., “Characterization of a Complementary Deoxyribonucleic Acid Coding for the Gamma Chain of Human Fibrinogen,”Biochemistry2:3250-3256 (1983).
Chung et al., “Characterization of Complementary Deoxyribonucleic Acid and Genomic Deoxyribonucleic Acid For The Beta Chain of Human Fibrinogen,”Biochemistry22:3244-3250 (1983).
Chung et al., “γ and γ′ Chains of Human Fibrinogen Are Produced by Alternative mRNA Processing,”Biochemistry23:4232-4326 (1984).
Clark et al., “Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice,”Nucl. Acids Res.25:1009-1014 (1997).
Clark et al., “Pharmaceuticals from transgenic livestock,”TIBTECH5:20-24 (1987).
Danishefsky et al., “Intracellular Fate of Fibrinogen B-beta Chain Expressed in COS Cells,”Biochim. Biophys. Acta1048:202-208 (1990).
Farrell et al., “Recombinant Human Fibrinogen and Sulfation of the γ′ Chain,”Biochemistry30:9414-9420 (1991).
Farrell et al., “Processing of the Carboxyl 15-Amino Acid Extension in the α-Chain of Fibrinogen,”J. Biol. Chem.268(14): 10351-10355 (1993).
Greenberg et al., “Expression of biologically active heterodimeric bovine follicle-stimulating hormone in milk of transgenic mice,”Proc. Natl. Acad. Sci. USA88:8327-8331 (1991).
Grinnell et al., “Native and Modified Recombinant Human Protein C: Functiion, Secretion, and Posttranslational Modification,”Adv. Appl. Biotechnol11:29-63 (1990).
Harris et al., “Developmental Regulation of the Sheep β-Lactoglobulin Gene in the Mammary Gland of Transgenic Mice,”Dev. Genet.12:299-307 (1991).
Hartwig et al., “Studies on the Assembly and Secretion of Fibrinogen,”J. Biol. Chem.266(10):6578-6585 (1991).
Huang et al., “Biosynthesis of Human Fibrinogen,”J. Biol. Chem.268(12):8919-8926 (1993).
Imam et al., “Isolation and Characterisation of cDNA Clones of the Aα and γ-chains of Human Fibrinogen,”Nucl. Acids Res.11(21):7427-7435 (1983).
Kant et al., “Partial mRNA Sequences for Human Aα, Bβ, and γ Fibrinogen Chains: Evolutionary and Functional Implications,”Proc. Natl. Acad. Sci. USA80:3953-3957 (1983).
Lee et al., “Production of Biomedical Proteins in the Milk of Transgenic Dairy Cows: The State Of The Art,”J. Controlled Release29:213-221 (1994).
Lord et al., “Purification and Characterization of Recombinant Human Fibrinogen,”Blood Coagulation and Fibrinolysis4:55-59 (1993).
Lord, “Expression of a Cloned Human Fibrinogen cDNA inEscherichia coli: Synthesis of an A Alpha Polypeptide,”DNA4(1):33-38 (1985).
Maschio et al., “Transgenic mice carrying the guinea-pig α-lactalbumin gene transcribe milk protein genes in their sebaceous glands during lactation,”Biochem. J.275:459-467 (1991).
Niemann et al., “Expression of human blood clotting factor VIII (FVIII) constructs in the mammary gland of transgenic mice and sheep,”J. Anim. Breed. Genet.113:437-444 (1996).
Pittius et al., “A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice,”Proc. Natl. Acad. Sci. USA85:5784-5878 (1988).
Prunkard et al., “Expression of Recombinant Human Fibrinogen in the Milk of Transgenic Mice,”Fibrinolysis8(1):102, Abstract 285 (1994).
Rixon et al., “Characterization of a Complementary Deoxyribonucleic Acid Coding for the Alpha Chain of Human Fibrinogen,”Biochemistry22:3237-3244 (1983).
Roy et al., “Assembly and Secretion of Recombinant Human Fibrinogen,”J. Biol. Chem.266(8):4758-4763 (1991).
Velander et al., “High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C,”Proc. Natl. Acad. Sci. USA89:12003-12007 (1992).
Velander et al., “Production of Biologically Active Human Protein C in the Milk of Transgenic Mice,”Ann. NY Acad. Sci.665:391-403 (1992).
Whitelaw et al., “Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice,”Transgenic Res.1:3-13 (1991).
Yarus et al., “Engineering Transgenes for Use in the Mammary Gland,”Genetic Engineering18:57-81 (1996).
Yarus et al., “The Carboxy-Terminal Domain of Human Surfactant Protein B is Not Required for Secretion in Milk of Transgenic Mice,”Frontiers in Bioscience2:a1-8 (1997).
Drohan William N.
Johnson John L.
Lubon Henryk
Velander William H.
American National Red Cross
Cooley Godward Kronish LLP
Crouch Deborah
University of North Carolina at Chapel Hill
Virgina Tech. Intellectual Properties, Inc.
LandOfFree
Transgenic nonhuman mammals producing fibrinogen in milk and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenic nonhuman mammals producing fibrinogen in milk and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic nonhuman mammals producing fibrinogen in milk and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3991232